GPP
XLRN
Great Point Partners’s Acceleron Pharma Inc. XLRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-58,056
| Closed | -$5.53M | – | 43 |
|
|
2020
Q2 | $5.53M | Sell |
58,056
-477,571
| -89% | -$45.5M | 0.44% | 31 |
|
|
2020
Q1 | $48.1M | Sell |
535,627
-464,373
| -46% | -$41.7M | 5.03% | 9 |
|
|
2019
Q4 | $53M | Sell |
1,000,000
-454,700
| -31% | -$24.1M | 4.62% | 10 |
|
|
2019
Q3 | $57.5M | Buy |
1,454,700
+5,400
| +0.4% | +$213K | 5.28% | 7 |
|
|
2019
Q2 | $59.5M | Buy |
1,449,300
+369,187
| +34% | +$15.2M | 6.61% | 6 |
|
|
2019
Q1 | $50.3M | Buy |
1,080,113
+43,538
| +4% | +$2.03M | 4.98% | 7 |
|
|
2018
Q4 | $45.1M | Buy |
1,036,575
+118,808
| +13% | +$5.17M | 5.71% | 4 |
|
|
2018
Q3 | $52.5M | Buy |
917,767
+159,767
| +21% | +$9.14M | 8.19% | 2 |
|
|
2018
Q2 | $36.8M | Buy |
758,000
+295,755
| +64% | +$14.3M | 5.1% | 6 |
|
|
2018
Q1 | $18.1M | Buy |
462,245
+289,121
| +167% | +$11.3M | 2.68% | 15 |
|
|
2017
Q4 | $7.35M | Buy |
173,124
+3,124
| +2% | +$133K | 1.25% | 26 |
|
|
2017
Q3 | $6.34M | Sell |
170,000
-323,500
| -66% | -$12.1M | 1.23% | 20 |
|
|
2017
Q2 | $15M | Buy |
493,500
+193,500
| +65% | +$5.88M | 2.69% | 16 |
|
|
2017
Q1 | $7.94M | Buy |
+300,000
| New | +$7.94M | 1.58% | 19 |
|